Synthesis of 4β-carbamoyl epipodophyllotoxins as potential antitumour agents
Ahmed Kamal1, B Ashwini Kumar, Paidakula Suresh
1Division of Organic Chemistry, Indian Institute of Chemical Technology, Hyderabad 500 607, India. ahmedkamal@iict.res.in
Abstract:
A series of new 4β-carbamoyl epipodophyllotoxin analogues have been synthesized and evaluated for their anticancer activity against eleven cancer cell lines including Zr-75-1, MCF7, KB, Gurav, DWD, Colo 205, A-549, Hop62, PC3, SiHa and A-2780. Most of the compounds exhibited better growth-inhibition activities against tested cell lines than that of etoposide. Further, compounds 6g and 6i are also evaluated for their DNA topoisomerase-II (topo-II) inhibition activity and they exhibited significant inhibition of topo-II catalytic activity comparable to etoposide.
Insights
New epipodophyllotoxin analogues show potent anticancer activity, outperforming etoposide in inhibiting cancer cell growth. Compounds 6g and 6i also demonstrated significant DNA topoisomerase-II inhibition, comparable to etoposide.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Molecular Biology
Background:
- Epipodophyllotoxins are a class of compounds with established anticancer properties.
- Developing novel analogues is crucial for improving efficacy and overcoming resistance.
- DNA topoisomerase-II (topo-II) is a key target in cancer chemotherapy.
Purpose of the Study:
- To synthesize and evaluate novel 4β-carbamoyl epipodophyllotoxin analogues for anticancer potential.
- To assess the efficacy of these compounds against a panel of human cancer cell lines.
- To investigate the mechanism of action, specifically the inhibition of DNA topoisomerase-II.
Main Methods:
- Synthesis of a series of 4β-carbamoyl epipodophyllotoxin analogues.
- Anticancer activity screening against eleven diverse cancer cell lines (e.g., Zr-75-1, MCF7, A-549, PC3).
- Evaluation of DNA topoisomerase-II catalytic activity inhibition for select compounds.
Main Results:
- Most synthesized analogues displayed superior growth-inhibition activity compared to etoposide across multiple cancer cell lines.
- Compounds 6g and 6i exhibited significant inhibition of DNA topoisomerase-II catalytic activity.
- The inhibitory effect of compounds 6g and 6i on topo-II was comparable to that of etoposide.
Conclusions:
- The novel 4β-carbamoyl epipodophyllotoxin analogues represent promising anticancer agents.
- These compounds demonstrate potent cytotoxic effects and a mechanism involving DNA topoisomerase-II inhibition.
- Further development of these analogues could lead to new therapeutic strategies for cancer treatment.
